Karin Kleigrewe
- Molecular Biology top 10%
- Plant Science top 5%
- Pharmacology top 2%
- Cell Biology top 5%
- Biotechnology top 2%
- Co-authors
- Hans‐Ulrich HumpfBettina TudzynskiPhilipp WiemannLena StudtThomas HofmannJin Woo BokDaren W. BrownNancy P. Keller
- Topics
- Gut microbiota and health (13 papers)Metabolomics and Mass Spectrometry Studies (8 papers)Microbial Natural Products and Biosynthesis (7 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Karin Kleigrewe
58 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 116
- Molecular Biology 976
- Plant Science 678
- Pharmacology 551
- Cell Biology 353
- Biotechnology 209
Countries citing papers authored by Karin Kleigrewe
This map shows the geographic impact of Karin Kleigrewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Kleigrewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Kleigrewe more than expected).
Fields of papers citing papers by Karin Kleigrewe
This network shows the impact of papers produced by Karin Kleigrewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Kleigrewe. The network helps show where Karin Kleigrewe may publish in the future.
Co-authorship network of co-authors of Karin Kleigrewe
This figure shows the co-authorship network connecting the top 25 collaborators of Karin Kleigrewe. A scholar is included among the top collaborators of Karin Kleigrewe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Kleigrewe. Karin Kleigrewe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 6 | |
| 7 | 43 | |
| 8 | 7 | |
| 9 | 17 | |
| 10 | 91 | |
| 11 | 93 | |
| 12 | 17 | |
| 13 | 105 | |
| 14 | 30 | |
| 15 | 57 | |
| 16 | 18 | |
| 17 | 130 | |
| 18 | 21 | |
| 19 | 17 | |
| 20 | 229 |
About Karin Kleigrewe
Karin Kleigrewe is a scholar working on Biological Psychiatry, Biotechnology and Endocrine and Autonomic Systems, having authored 59 papers that have together received 2.1k indexed citations. Recurring topics across this work include Gut microbiota and health (13 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Microbial Natural Products and Biosynthesis (7 papers). The work is most often cited by research in Pharmacology (551 citations), Biotechnology (209 citations) and Cell Biology (353 citations). Karin Kleigrewe has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Hans‐Ulrich Humpf, Bettina Tudzynski, Philipp Wiemann, Lena Studt, Thomas Hofmann, Jin Woo Bok, Daren W. Brown, Nancy P. Keller, Marita Beyer and Dirk Haller. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.